Norrin Ameliorates Retinal Ganglion Cell Apoptosis by Normalizing VEGF and PEDF Dysregulation in Diabetic Retinopathy
Cells · 14.04.2026 · 15 (8) · 689
DOI: 10.3390/cells15080689 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 14.04.2026. Verfasst von Chan-Hee Moon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biochemistry, Kangwon National University School of Medicine, Chuncheon 24341, Kangwon-do, Republic of Korea. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Eye Proteins, Serpins, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Research Grant from Institute of Medical Sciences, Kangwon National University, the National Research Foundation of Korea, National Research Foundation of Korea.
Abstract (Originalsprache)
Diabetic retinopathy is increasingly recognized as a neurovascular disorder rather than a purely vascular disease; however, therapeutic strategies targeting retinal neurodegeneration remain limited. In this study, we investigated the protective effects of norrin against hyperglycemia-induced retinal neurodegeneration and elucidated its underlying molecular mechanisms in diabetic mice. We found that retinal neurodegeneration may precede microvascular leakage in diabetic retinas. Norrin, which is expressed in the inner retina, was significantly downregulated under diabetic conditions. Intravitreal supplementation of norrin markedly attenuated hyperglycemia-induced neurodegenerative processes, leading to retinal ganglion cell (RGC) apoptosis, including oxidative stress, inflammation, and neuropathological alterations such as reactive gliosis, glutamate excitotoxicity, and synaptic dysfunction. Norrin also reduced hyperglycemia-induced microvascular leakage and RGC apoptosis by normalizing vascular endothelial growth factor (VEGF) overexpression and restoring pigment epithelium-derived factor (PEDF) levels. Notably, PEDF upregulated by norrin effectively suppressed neurodegenerative processes induced by hyperglycemia or VEGF, thereby preserving RGC function. These findings identify norrin as a critical modulator of hyperglycemia-induced retinal neurodegeneration through restoration of the VEGF–PEDF balance. Our results highlight norrin as a potential therapeutic target for early neurodegenerative changes in diabetic retinopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cellular Biochemistry, Kangwon National University School of Medicine, Chuncheon 24341, Kangwon-do, Republic of Korea.
- Department of Anesthesiology, Kangwon National University School of Medicine, Chuncheon 24341, Kangwon-do, Republic of Korea.
ORCID-Profile: Kwon-Soo Ha
Förderung
- the Research Grant from Institute of Medical Sciences, Kangwon National University
- the National Research Foundation of Korea
- National Research Foundation of Korea
- Institute of Medical Sciences, Kangwon National University
Zitieren
APA
Moon, C. H., Koh, T. Y., Yoon, J. S., Kim, M., & Ha, K. S. (2026). Norrin Ameliorates Retinal Ganglion Cell Apoptosis by Normalizing VEGF and PEDF Dysregulation in Diabetic Retinopathy. Cells, 15(8), 689. https://doi.org/10.3390/cells15080689
Vancouver
Moon CH, Koh TY, Yoon JS, Kim M, Ha KS. Norrin Ameliorates Retinal Ganglion Cell Apoptosis by Normalizing VEGF and PEDF Dysregulation in Diabetic Retinopathy. Cells. 2026;15(8):689. doi:10.3390/cells15080689
BibTeX
@article{Moon2026,
author = {Moon, Chan-Hee and Koh, Tae-Yong and Yoon, Ji-Seok and Kim, Minsoo and Ha, Kwon-Soo},
title = {Norrin Ameliorates Retinal Ganglion Cell Apoptosis by Normalizing VEGF and PEDF Dysregulation in Diabetic Retinopathy},
journal = {Cells},
year = {2026},
volume = {15},
number = {8},
pages = {689},
doi = {10.3390/cells15080689}
}
EUVIMED